(Q43583635)

English

The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats

scientific article published in January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

author name string

M Gerlach

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A Y Xiao

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

W Kuhn

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

R Lehnfeld

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

P Waldmeier

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

K H Sontag

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

P Riederer

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Journal of Neural Transmission

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

189-204

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Oxidative stress: free radical production in neural degeneration.

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Catechol-O-methyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Tolcapone and neurotoxicity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Treatment of Parkinson's disease should begin with a dopamine agonist

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Hydroxylation of aromatic compounds as indices of hydroxyl radical production: a cautionary note revisited.

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Measuring the progression of idiopathic Parkinson's disease with [123I] beta-CIT SPECT.

1 reference

https://api.crossref.org/works/10.1007%2FS007020170087

21 January 2018

Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/11314772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selegiline as the primary treatment of Parkinson's disease--a long-term double-blind study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11314772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion

1 reference

https://pubmed.ncbi.nlm.nih.gov/11314772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/11314772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Separation of dihydroxybenzoates, indicators of in-vivo hydroxyl free radical formation, in the presence of transmitter amines and some metabolites in rodent brain, using high-performance liquid chromatography with electrochemical detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11314772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11314772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11314772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S007020170087

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43583635&oldid=2206141482"